{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:33:16Z","timestamp":1787135596085,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"crossref","award":["Unresctricted grant"],"award-info":[{"award-number":["Unresctricted grant"]}],"id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1037-1","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T13:03:35Z","timestamp":1551704615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is early detection of late-onset Pompe disease a pneumologist\u2019s affair? A lesson from an Italian screening study"],"prefix":"10.1186","volume":"14","author":[{"name":"on behalf of AIPO Pneumoloped Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-768X","authenticated-orcid":false,"given":"Marco","family":"Confalonieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vitacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Crescimanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ceriana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Antonaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Zacchigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1566524024605789","volume":"2","author":"N Raben","year":"2002","unstructured":"Raben N, Plotz P, Byrne BJ. Acid-alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med. 2002;2:145\u201366.","journal-title":"Curr Mol Med"},{"key":"1037_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guidelines. Genetics Med. 2006;8:267\u201388.","journal-title":"Genetics Med"},{"key":"1037_CR3","first-page":"82","volume":"32","author":"F Manganelli","year":"2013","unstructured":"Manganelli F, Ruggiero L. Clinical features of Pompe disease. Acta Myol. 2013;32:82\u20134.","journal-title":"Acta Myol"},{"key":"1037_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","volume":"120","author":"J Chan","year":"2017","unstructured":"Chan J, Desai AK, Kazi ZB, Corey K, Austin S, Hobson-Webb LD, et al. The emerging phenotype of late-onset Pompe disease: a systematic literature review. Mol Gen Metabol. 2017;120:163\u201372.","journal-title":"Mol Gen Metabol"},{"key":"1037_CR5","doi-asserted-by":"crossref","unstructured":"Winkel LP, Hagemans ML, Van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, et al. The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol. 2005;252:875\u201384.","DOI":"10.1007\/s00415-005-0922-9"},{"key":"1037_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","volume":"103","author":"U Mellies","year":"2009","unstructured":"Mellies U, Lofaso F. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med. 2009;103:477\u201384.","journal-title":"Respir Med"},{"key":"1037_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/jnnp.47.5.549","volume":"47","author":"RWM Keunen","year":"1984","unstructured":"Keunen RWM, Lambregts PCLA, Op de Coul AAW, Joosten EMG. Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry. 1984;47:549\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1037_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40248-018-0145-4","volume":"13","author":"F Menzella","year":"2018","unstructured":"Menzella F, Codeluppi L, Lusuardi M, Galeone C, Valzania F, Facciolongo N. Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report. Multidiscip Respir Med. 2018;13:32.","journal-title":"Multidiscip Respir Med"},{"key":"1037_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg Van der","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alpha in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362:1396\u2013406.","journal-title":"N Engl J Med"},{"key":"1037_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mus.22329","volume":"45","author":"EJ Cupler","year":"2012","unstructured":"Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barhon NJ, et al. Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve. 2012;45:319\u201333.","journal-title":"Muscle Nerve"},{"key":"1037_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Stewart A, Kanters S, Hamed A, Jansen J, Chan K, et al. Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol. 2017;264:621\u201330.","journal-title":"J Neurol"},{"key":"1037_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2016.05.013","volume":"119","author":"A Ploeg van der","year":"2016","unstructured":"van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, et al. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: the EMBASSY study. Mol Genet Metab. 2016;119:115\u201323.","journal-title":"Mol Genet Metab"},{"key":"1037_CR13","first-page":"5","volume":"87","author":"O Musumeci","year":"2016","unstructured":"Musumeci O, la Marca G, Spada M, Mondello S, Danesino C, Comi GP, et al. LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population. J Neurol Neurosurg Psychiatry. 2016;87:5\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1037_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.rmed.2013.03.004","volume":"107","author":"N Ambrosino","year":"2013","unstructured":"Ambrosino N, Confalonieri M, Crescimanno G, Vianello A, Vitacca M. The role of respiratory management of Pompe disease. Respir Med. 2013;107:1124\u201332.","journal-title":"Respir Med"},{"key":"1037_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","volume":"8","author":"H Zhang","year":"2006","unstructured":"Zhang H, Kallwas H, Young SP, Carr C, Dai J, Kishnani PS, et al. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med Dis. 2006;8:302\u20136.","journal-title":"Genet Med Dis"},{"issue":"Pt 3","key":"1037_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/brain\/awh384","volume":"128","author":"MLC Hagemans","year":"2005","unstructured":"Hagemans MLC, Winkel LPF, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, et al. Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients. Brain. 2005;128(Pt 3):671\u20137.","journal-title":"Brain"},{"key":"1037_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","volume":"17","author":"W Muller-Felber","year":"2007","unstructured":"Muller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, et al. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long- term follow-up in 18 patients. Neuromuscul Disord. 2007;17:698\u2013706.","journal-title":"Neuromuscul Disord"},{"key":"1037_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mus.21393","volume":"40","author":"American Association of Neuromuscular & Electrodiagnostic Medicine","year":"2009","unstructured":"American Association of Neuromuscular & Electrodiagnostic Medicine. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve. 2009;40:149\u201360.","journal-title":"Muscle Nerve"},{"key":"1037_CR19","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","volume":"161","author":"PS Kishnani","year":"2013","unstructured":"Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry. Am J Genet A. 2013;161:2431\u201343.","journal-title":"Am J Genet A"},{"key":"1037_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4187\/respcare.01157","volume":"56","author":"R Scala","year":"2011","unstructured":"Scala R, Corrado A, Confalonieri M, et al. Increased number and expertise of Italian respiratory high-dependency care units: the second national survey. Respir Care. 2011;56:1100\u20137.","journal-title":"Respir Care"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1037-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T10:24:36Z","timestamp":1721039076000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1037-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was given by the C.E.R.U. Friuli-Venezia Giulia (ref.# 67\/2014).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}